Study: Arimoclomol Shows Positive Results in the Treatment of Niemann-Pick Disease
source: pixabay.com

Study: Arimoclomol Shows Positive Results in the Treatment of Niemann-Pick Disease

  Orphazyme, a biopharmaceutical company, has recently released the data from their study of arimoclomol. This product is meant for the treatment of Niemann-Pick disease type C (NPC). Orphazyme specializes…

Continue Reading Study: Arimoclomol Shows Positive Results in the Treatment of Niemann-Pick Disease
2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
source: pixabay.com

2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza

  According to an article in BioSpace, the FDA recently approved the PARP inhibitor Lynparza that was developed by Merck and AstraZeneca to be used as maintenance therapy for pancreatic…

Continue Reading 2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
Researchers Discover New Rare Disease Called CRIA Syndrome And a Potential Treatment
source: pixabay.com

Researchers Discover New Rare Disease Called CRIA Syndrome And a Potential Treatment

Doctor Daniel Kastner, director of NHGRI, recently uncovered a new rare disease along with his research team. It’s called CRIA syndrome. This discovery has been published in Nature. CRIA CRIA…

Continue Reading Researchers Discover New Rare Disease Called CRIA Syndrome And a Potential Treatment
Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
source: pixabay.com

Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients

A New Working Group A team of healthcare professionals from the Institute for Quality and Efficacy in Health Care, the Drug Commission of the German Medical Association, and the Charité…

Continue Reading Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
Close Menu